Abstract
Oxidative stress (OS) is the main cause of secondary damage following intracerebral hemorrhage (ICH). The polarity expression of aquaporin-4 (AQP4) has been shown to be important in maintaining the homeostasis of water transport and preventing post-injury brain edema in various neurological disorders. This study primarily aimed to investigate the effect of the oxygen free radical scavenger, edaravone, on AQP4 polarity expression in an ICH mouse model and determine whether it involves in AQP4 polarity expression via the OS/MMP9/β-dystroglycan (β-DG) pathway. The ICH mouse model was established by autologous blood injection into the basal nucleus. Edaravone or the specific inhibitor of matrix metalloproteinase 9 (MMP9), MMP9-IN-1, called MMP9-inh was administered 10 min after ICH via intraperitoneal injection. ELISA detection, neurobehavioral tests, dihydroethidium staining (DHE staining), intracisternal tracer infusion, hematoxylin and eosin (HE) staining, immunofluorescence staining, western blotting, Evans blue (EB) permeability assay, and brain water content test were performed. The results showed that OS was exacerbated, AQP4 polarity was lost, drainage function of brain fluids was damaged, brain injury was aggravated, expression of AQP4, MMP9, and GFAP increased, while the expression of β-DG decreased after ICH. Edaravone reduced OS, restored brain drainage function, reduced brain injury, and downregulated the expression of AQP4, MMP9. Both edaravone and MMP9-inh alleviated brain edema, maintained blood–brain barrier (BBB) integrity, mitigated the loss of AQP4 polarity, downregulated GFAP expression, and upregulated β-DG expression. The current study suggests that edaravone can maintain AQP4 polarity expression by inhibiting the OS /MMP9/β-DG pathway after ICH.
Similar content being viewed by others
Data Availability
The datasets used and/or analyzed in the current study are available from the corresponding authors on request.
References
Keep RF, Hua Y, Xi G (2012) Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol 11(8):720–731. https://doi.org/10.1016/S1474-4422(12)70104-7
Shao Z, Tu S, Shao A (2019) Pathophysiological mechanisms and potential therapeutic targets in intracerebral hemorrhage. Front Pharmacol 10. https://doi.org/10.3389/fphar.2019.01079
Zhu H, Wang Z, Yu J, Yang X, He F, Liu Z et al (2019) Role and mechanisms of cytokines in the secondary brain injury after intracerebral hemorrhage. Prog Neurobiol 178:6–30. https://doi.org/10.1016/j.pneurobio.2019.03.003
Shao A, Zhu Z, Li L, Zhang S, Zhang J (2019) Emerging therapeutic targets associated with the immune system in patients with intracerebral haemorrhage (ICH): from mechanisms to translation. EBioMedicine 45:615–623. https://doi.org/10.1016/j.ebiom.2019.06.012
Chen W, Guo C, Feng H, Chen Y (2021) Mitochondria: novel mechanisms and therapeutic targets for secondary brain injury after intracerebral hemorrhage. Front Aging Neurosci 12 https://doi.org/10.3389/fnagi.2020.615451
Candelario-Jalil E, Dijkhuizen RM, Magnus T (2022) Neuroinflammation, stroke, blood-brain barrier dysfunction, and imaging modalities. Stroke 53(5):1473–1486. https://doi.org/10.1161/STROKEAHA.122.036946
Zhang X, Zhu HC, Yang D, Zhang FC, Mane R, Sun SJ et al (2022) Association between cerebral blood flow changes and blood-brain barrier compromise in spontaneous intracerebral haemorrhage. Clin Radiol 77(11):833–839. https://doi.org/10.1016/j.crad.2022.05.028
Jia P, He J, Li Z, Wang J, Jia L, Hao R, et al. (2021) Profiling of blood-brain barrier disruption in mouse intracerebral hemorrhage models: collagenase injection vs. autologous arterial whole blood infusion. Front Cell Neurosci 15. https://doi.org/10.3389/fncel.2021.699736
Lushchak VI (2014) Free radicals, reactive oxygen species, oxidative stress and its classification. Chem Biol Interact 224:164–175. https://doi.org/10.1016/j.cbi.2014.10.016
Katsu M, Niizuma K, Yoshioka H, Okami N, Sakata H, Chan PH (2010) Hemoglobin-induced oxidative stress contributes to matrix metalloproteinase activation and blood-brain barrier dysfunction in vivo. J Cereb Blood Flow Metab 30(12):1939–1950. https://doi.org/10.1038/jcbfm.2010.45
Hu X, Wang Y, Du W, Liang L-J, Wang W, Jin X (2022) Role of glial cell-derived oxidative stress in blood-brain barrier damage after acute ischemic stroke. Oxid Med Cell Longev 2022. https://doi.org/10.1155/2022/7762078
Huang LJ, Zhan D, Xing Y, Yan YQ, Li Q, Zhang JY, et al. (2023) FGL2 deficiency alleviates maternal inflammation-induced blood-brain barrier damage by blocking PI3K/NF-kappa B mediated endothelial oxidative stress. Front Immunol 14. https://doi.org/10.3389/fimmu.2023.1157027
Offen D, Gilgun-Sherki Y, Barhum Y, Benhar M, Grinberg L, Reich R et al (2004) A low molecular weight copper chelator crosses the blood-brain barrier and attenuates experimental autoimmune encephalomyelitis. J Neurochem 89(5):1241–1251. https://doi.org/10.1111/j.1471-4159.2004.02428.x
Kurata S (2000) Selective activation of p38 MAPK cascade and mitotic arrest caused by low level oxidative stress. J Biol Chem 275(31):23413–23416. https://doi.org/10.1074/jbc.C000308200
Ronaldson PT, Davis TP (2020) Regulation of blood-brain barrier integrity by microglia in health and disease: a therapeutic opportunity. J Cereb Blood Flow Metab 40(1_SUPPL):S6–S24. https://doi.org/10.1177/0271678X20951995
Lee KH, Cha M, Lee BH (2021) Crosstalk between neuron and glial cells in oxidative injury and neuroprotection. Int J Mol Sci 22(24). https://doi.org/10.3390/ijms222413315
Saadoun S, Papadopoulos MC (2010) Aquaporin-4 in brain and spinal cord oedema. Neuroscience 168(4):1036–1046. https://doi.org/10.1016/j.neuroscience.2009.08.019
Manley GT, Fujimura M, Ma TH, Noshita N, Filiz F, Bollen AW et al (2000) Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med 6(2):159–163. https://doi.org/10.1038/72256
Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, et al. (2012) A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med 4(147). https://doi.org/10.1126/scitranslmed.3003748
Zou Y-Y, Yuan Y, Kan EM, Lu J, Ling E-A (2014) Combustion smoke-induced inflammation in the olfactory bulb of adult rats. J Neuroinflammation 11. https://doi.org/10.1186/s12974-014-0176-5
Wang F-x, Xu C-l, Su C, Li J, Lin J-Y (2022) beta-Hydroxybutyrate attenuates painful diabetic neuropathy via restoration of the aquaporin-4 polarity in the spinal glymphatic system. Front Neurosci 16. https://doi.org/10.3389/fnins.2022.926128
Gao M, Lu W, Shu Y, Yang Z, Sun S, Xu J et al (2020) Poldip2 mediates blood-brain barrier disruption and cerebral edema by inducing AQP4 polarity loss in mouse bacterial meningitis model. CNS Neurosci Ther 26(12):1288–1302. https://doi.org/10.1111/cns.13446
Neely JD, Amiry-Moghaddam M, Ottersen OP, Froehner SC, Agre P, Adams ME (2001) Syntrophin-dependent expression and localization of Aquaporin-4 water channel protein. Proc Natl Acad Sci USA 98(24):14108–13. https://doi.org/10.1073/pnas.241508198
Amiry-Moghaddam M, Frydenlund DS, Ottersen OP (2004) Anchoring of aquaporin-4 in brain: molecular mechanisms and implications for the physiology and pathophysiology of water transport. Neuroscience 129(4):999–1010. https://doi.org/10.1016/j.neuroscience.2004.08.049
Waite A, Brown SC, Blake DJ (2012) The dystrophin-glycoprotein complex in brain development and disease. Trends Neurosci 35(8):487–496. https://doi.org/10.1016/j.tins.2012.04.004
Bozzi M, Inzitari R, Sbardell D, Monaco S, Pavoni E, Gioia M et al (2009) Enzymatic processing of β-dystroglycan recombinant ectodomain by MMP-9: identification of the main cleavage site. IUBMB Life 61(12):1143–1152. https://doi.org/10.1002/iub.273
Yan W, Zhao X, Chen H, Zhong D, Jin J, Qin Q et al (2016) beta-Dystroglycan cleavage by matrix metalloproteinase-2/-9 disturbs aquaporin-4 polarization and influences brain edema in acute cerebral ischemia. Neuroscience 326:141–157. https://doi.org/10.1016/j.neuroscience.2016.03.055
Shichinohe H, Kuroda S, Yasuda H, Ishikawa T, Iwai M, Horiuchi M et al (2004) Neuroprotective effects of the free radical scavenger Edaravone (MCI-186) in mice permanent focal brain ischemia. Brain Res 1029(2):200–206. https://doi.org/10.1016/j.brainres.2004.09.055
Lu F, Nakamura T, Toyoshima T, Liu Y, Hirooka K, Kawai N et al (2012) Edaravone, a free radical scavenger, attenuates behavioral deficits following transient forebrain ischemia by inhibiting oxidative damage in gerbils. Neurosci Lett 506(1):28–32. https://doi.org/10.1016/j.neulet.2011.10.041
Nakamura T, Kuroda Y, Yamashita S, Zhang X, Miyamoto O, Tamiya T et al (2008) Edaravone attenuates brain edema and neurologic deficits in a rat model of acute intracerebral hemorrhage. Stroke 39(2):463–469. https://doi.org/10.1161/STROKEAHA.107.486654
Zhang Y, Yang Y, Zhang G-Z, Gao M, Ge G-Z, Wang Q-Q et al (2016) Stereotactic administration of edaravone ameliorates collagenase-induced intracerebral hemorrhage in rat. CNS Neurosci Ther 22(10):824–835. https://doi.org/10.1111/cns.12584
Hua Y, Zhou L, Yang W, An W, Kou X, Ren J, et al. (2010) Y-2 reduces oxidative stress and inflammation and improves neurological function of collagenase-induced intracerebral hemorrhage rats. Eur J Pharmacol 910. https://doi.org/10.1016/j.ejphar.2021.174507
Yang J, Liu M, Zhou J, Zhang S, Lin S, Zhao H (2011) Edaravone for acute intracerebral haemorrhage. Cochrane Database Syst Rev (2). https://doi.org/10.1002/14651858.CD007755.pub2
Zhao F, Liu Z (2014) Beneficial effects of edaravone on the expression of serum matrix metalloproteinase-9 after cerebral hemorrhage. Neurosciences 19(2):106–110
Yang Z, Huang J, Liao Y, Gan S, Zhu S, Xu S et al (2022) ER stress is involved in mast cells degranulation via IRE1 alpha/miR-125/ Lyn pathway in an experimental intracerebral hemorrhage mouse model. Neurochem Res 47(6):1598–1609. https://doi.org/10.1007/s11064-022-03555-7
Kin H, Zhao ZQ, Sun HY, Wang NP, Corvera JS, Halkos ME et al (2004) Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res 62(1):74–85. https://doi.org/10.1016/j.cardiores.2004.01.006
Iliff JJ, Chen MJ, Plog BA, Zeppenfeld DM, Soltero M, Yang L et al (2014) Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury. J Neurosci 34(49):16180–16193. https://doi.org/10.1523/JNEUROSCI.3020-14.2014
Sule R, Rivera G, Gomes AV (2023) Western blotting (immunoblotting): history, theory, uses, protocol and problems. Biotechniques https://doi.org/10.2144/btn-2022-0034
Chen H, Yoshioka H, Kim GS, Jung JE, Okami N, Sakata H et al (2011) Oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for neuroprotection. Antioxid Redox Signal 14(8):1505–17. https://doi.org/10.1089/ars.2010.3576
Li W, Yang S (2016) Targeting oxidative stress for the treatment of ischemic stroke: upstream and downstream therapeutic strategies. Brain Circ 2(4):153–163. https://doi.org/10.4103/2394-8108.195279
Icme F, Erel O, Avci A, Satar S, Gulen M, Acehan S (2015) The relation between oxidative stress parameters, ischemic stroke, and hemorrhagic stroke. Turk J Med Sci 45(4):947–953. https://doi.org/10.3906/sag-1402-9
Neves JD, Vizuete AF, Nicola F, Da Re C, Rodrigues AF, Schmitz F et al (2018) Glial glutamate transporters expression, glutamate uptake, and oxidative stress in an experimental rat model of intracerebral hemorrhage. Neurochem Int 116:13–21. https://doi.org/10.1016/j.neuint.2018.03.003
Zeng Y, Zhu G, Zhu M, Song J, Cai H, Song Y, et al. (2022) Edaravone attenuated particulate matter-induced lung inflammation by inhibiting ROS-NF-kappa B signaling pathway. Oxid Med Cell Longev 2022 https://doi.org/10.1155/2022/6908884
Wu H-T, Yu Y, Li X-X, Lang X-Y, Gu R-Z, Fan S-R et al (2021) Edaravone attenuates H2O2 or glutamate-induced toxicity in hippocampal neurons and improves AlCl3/D-galactose induced cognitive impairment in mice. Neurotoxicology 85:68–78. https://doi.org/10.1016/j.neuro.2021.05.005
Klatzo I (1994) Evolution of brain edema concepts. Acta Neurochir Suppl 60:3–6
Papadopoulos MC, Verkman AS (2007) Aquaporin-4 and brain edema. Pediatr Nephrol 22(6):778–784. https://doi.org/10.1007/s00467-006-0411-0
Zhang C, Lin J, Wei F, Song J, Chen W, Shan L et al (2018) Characterizing the glymphatic influx by utilizing intracisternal infusion of fluorescently conjugated cadaverine. Life Sci 201:150–160. https://doi.org/10.1016/j.lfs.2018.03.057
Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA et al (2012) A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med 4(147):147ra11-ra11. https://doi.org/10.1126/scitranslmed.3003748
Wolburg-Buchholz K, Mack AF, Steiner E, Pfeiffer F, Engelhardt B, Wolburg H (2009) Loss of astrocyte polarity marks blood-brain barrier impairment during experimental autoimmune encephalomyelitis. Acta Neuropathol 118(2):219–233. https://doi.org/10.1007/s00401-009-0558-4
Krafft PR, Caner B, Klebe D, Rolland WB, Tang J, Zhang JH (2010) PHA-543613 preserves blood-brain barrier integrity after intracerebral hemorrhage in mice. Stroke. 44(6):1743-+. https://doi.org/10.1161/STROKEAHA.111.000427
Steiner E, Enzmann GU, Lin S, Ghavampour S, Hannocks M-J, Zuber B et al (2012) Loss of astrocyte polarization upon transient focal brain ischemia as a possible mechanism to counteract early edema formation. Glia 60(11):1646–1659. https://doi.org/10.1002/glia.22383
Noell S, Wolburg-Buchholz K, Mack AF, Beedle AM, Satz JS, Campbell KP et al (2011) Evidence for a role of dystroglycan regulating the membrane architecture of astroglial endfeet. Eur J Neurosci 33(12):2179–2186. https://doi.org/10.1111/j.1460-9568.2011.07688.x
Gondo A, Shinotsuka T, Morita A, Abe Y, Yasui M, Nuriya M (2014) Sustained down-regulation of beta-dystroglycan and associated dysfunctions of astrocytic endfeet in epileptic cerebral cortex. J Biol Chem 289(44):30279–30288. https://doi.org/10.1074/jbc.M114.588384
Velasquez M, O'Sullivan C, Brockett R, Mikels-Vigdal A, Mikaelian I, Smith V, et al. (2023) Characterization of active MMP9 in chronic inflammatory diseases using a novel anti-MMP9 antibody. Antibodies (Basel, Switzerland) 12(1) https://doi.org/10.3390/antib12010009
Sbardella D, Inzitari R, Iavarone F, Gioia M, Marini S, Sciandra F et al (2012) Enzymatic processing by MMP-2 and MMP-9 of wild-type and mutated mouse ss-dystroglycan. IUBMB Life 64(12):988–994. https://doi.org/10.1002/iub.1095
Chen C, Fan P, Zhang L, Xue K, Hu J, Huang J et al (2023) Bumetanide rescues aquaporin-4 depolarization via suppressing p-Dys-troglycan cleavage and provides neuroprotection in rat retinal ischemia-reperfusion injury. Neuroscience 510:95–108. https://doi.org/10.1016/j.neuroscience.2022.11.033
Simone L, Pisani F, Mola MG, De Bellis M, Merla G, Micale L et al (2019) AQP4 aggregation state is a determinant for glioma cell fate. Can Res 79(9):2182–2194. https://doi.org/10.1158/0008-5472.CAN-18-2015
Hiroaki Y, Tani K, Kamegawa A, Gyobu N, Nishikawa K, Suzuki H et al (2006) Implications of the aquaporin-4 structure on array formation and cell adhesion. J Mol Biol 355(4):628–639. https://doi.org/10.1016/j.jmb.2005.10.081
Silberstein C, Bouley R, Huang Y, Fang PK, Pastor-Soler N, Brown D et al (2004) Membrane organization and function of M1 and M23 isoforms of aquaporin-4 in epithelial cells. Am J Physiol Renal Physiol 287(3):F501–F511. https://doi.org/10.1152/ajprenal.00439.2003
Funding
This work was supported by the National Natural Science Foundation of China (NSFC 82171457), Natural Science Foundation of Chongqing (CSTB2022NSCQ-MSX1083), and Program for Youth Innovation in Future Medicine, Chongqing Medical University (W0031).
Author information
Authors and Affiliations
Contributions
All authors contributed to the conception and design of the study. Material preparation, data collection, and analysis were performed by Zhenhua Wang, Yuan Li, and Zhixu Wang. The initial draft of the manuscript was written by Zhenghua Wang, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Ethics Approval
This project involves the purchase of animals from the Animal Center of Chongqing Medical University. The experimental protocol has been reviewed by the Institutional Animal Care and Use Committee of Chongqing Medical University (IACUC-CQMU) and is in accordance with principles of animal protection, animal welfare, and ethics. It complies with relevant regulations on the welfare and ethics of experimental animals in the country (Approval No: IACUC-CQMU-2023–0117).
Consent to Participate
Not applicable.
Consent for Publication
Not applicable.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Wang, Z., Li, Y., Wang, Z. et al. Edaravone Maintains AQP4 Polarity Via OS/MMP9/β-DG Pathway in an Experimental Intracerebral Hemorrhage Mouse Model. Mol Neurobiol (2024). https://doi.org/10.1007/s12035-024-04028-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12035-024-04028-4